Cargando…
Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379103/ https://www.ncbi.nlm.nih.gov/pubmed/35983481 http://dx.doi.org/10.2147/IJN.S385585 |
_version_ | 1784768619882741760 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9379103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-93791032022-08-17 Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction] Int J Nanomedicine Retraction Dove 2022-08-11 /pmc/articles/PMC9379103/ /pubmed/35983481 http://dx.doi.org/10.2147/IJN.S385585 Text en © 2022 Dove Medical Press. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Retraction Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction] |
title | Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction] |
title_full | Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction] |
title_fullStr | Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction] |
title_full_unstemmed | Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction] |
title_short | Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction] |
title_sort | thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against egfr in t47d breast cancer cells [retraction] |
topic | Retraction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379103/ https://www.ncbi.nlm.nih.gov/pubmed/35983481 http://dx.doi.org/10.2147/IJN.S385585 |